NRX Pharmaceuticals (NRXP) Stock Price, Quote, News & History

Comments

NRX Pharmaceuticals Inc (NRXP) Stock Price, Quote, News & History

NRXPNASDAQ

Trade with Public

$1.73

0.031.76%

At close: Mar 9, 5:00 PM EST

$1.74

0.010.58%

After Hours: 7:38 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.64

Close

$1.73

Volume / Avg.

743.55K / 951.34K

Day Range

$1.62 - $1.76

52 Wk Range

1.58 - 3.84

Market Cap

$51.51M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

8.94%

Days to Cover

5.37

Recent NRX Pharmaceuticals Inc News

Partner Content

NRx Builds Momentum From FDA Progress To Strategic Expansion

Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.50M

Investing Cash Flow (TTM)

-2.56M

Financing Cash Flow (TTM)

20.60M

Free Cash Flow (TTM)

-12.50M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

5.54M

Analyst Trends and Forecast

2

Nov 25

4

Dec 25

3

Jan

2

Feb

2

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$57.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

1.38

PEG Ratio (TTM)

-

PS Ratio (TTM)

120.64

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-136.28%

Earnings Yield % (FWD)

72.57%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.81

Company Debt

Total Debt

$10.06M

LT Debt

-

LT Debt Issuance (TTM)

$9.37M

LT Debt Repayment (TTM)

-$3.60M

Total Cash

$7.18M

Debt to Equity

-

Issuance of Debt (TTM)

$5.76M

Repayment of Debt (TTM)

-$4.00M

Key Statistics

Open

$1.64

Close

$1.73

Volume / Avg.

743.55K / 951.34K

Day Range

$1.62 - $1.76

52 Wk Range

1.58 - 3.84

Market Cap

$51.51M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

8.94%

Days to Cover

5.37

About

Sector

Health Care

Industry

Pharmaceuticals

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announce...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy NRX Pharmaceuticals (NRXP) stock?

A

You can purchase shares of NRX Pharmaceuticals (NASDAQ:NRXP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are NRX Pharmaceuticals (NRXP) competitors?

A

Other companies in NRX Pharmaceuticals’s space includes: Cingulate Inc (NASDAQ:CING), Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), Lipocine Inc (NASDAQ:LPCN), Incannex Healthcare Inc (NASDAQ:IXHL) and Nutriband Inc (NASDAQ:NTRB).

Q

What is the forecast, or price target, for NRX Pharmaceuticals (NRXP) stock?

A

NRX Pharmaceuticals has a consensus price target of $31.43.

Q

What is the current price for NRX Pharmaceuticals (NRXP)?

A

The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $1.74 last updated March 9, 2026 at 7:38 PM EDT.

Q

Does NRX Pharmaceuticals (NRXP) pay a dividend?

A

There are no upcoming dividends for NRX Pharmaceuticals.

Q

When is NRX Pharmaceuticals (NASDAQ:NRXP) reporting earnings?

A

NRX Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is NRX Pharmaceuticals (NRXP) going to split?

A

There is no upcoming split for NRX Pharmaceuticals.

Q

What sector and industry does NRX Pharmaceuticals (NRXP) operate in?

A

NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Cumberland Pharmaceuticals Inc

Incannex Healthcare Inc

Telomir Pharmaceuticals Inc

NASDAQ:TELO

$1.32

-0.76%

Tvardi Therapeutics Inc

Key Statistics

Open

$1.64

Close

$1.73

Volume / Avg.

743.55K / 951.34K

Day Range

$1.62 - $1.76

52 Wk Range

1.58 - 3.84

Market Cap

$51.51M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

8.94%

Days to Cover

5.37

Recent NRX Pharmaceuticals Inc News

Partner Content

NRx Builds Momentum From FDA Progress To Strategic Expansion

Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.50M

Investing Cash Flow (TTM)

-2.56M

Financing Cash Flow (TTM)

20.60M

Free Cash Flow (TTM)

-12.50M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

5.54M

Analyst Trends and Forecast

2

Nov 25

4

Dec 25

3

Jan

2

Feb

2

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$57.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

1.38

PEG Ratio (TTM)

-

PS Ratio (TTM)

120.64

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-136.28%

Earnings Yield % (FWD)

72.57%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.81

Company Debt

Total Debt

$10.06M

LT Debt

-

LT Debt Issuance (TTM)

$9.37M

LT Debt Repayment (TTM)

-$3.60M

Total Cash

$7.18M

Debt to Equity

-

Issuance of Debt (TTM)

$5.76M

Repayment of Debt (TTM)

-$4.00M

Key Statistics

Open

$1.64

Close

$1.73

Volume / Avg.

743.55K / 951.34K

Day Range

$1.62 - $1.76

52 Wk Range

1.58 - 3.84

Market Cap

$51.51M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

8.94%

Days to Cover

5.37

About

Sector

Health Care

Industry

Pharmaceuticals

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announce...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry